Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Technologies - Radioactive and Nonradioactive Probes: Novel Radioactive Probes

Application of click chemistry in the synthesis of 68Ga-labeled agents

Izabela Tworowska, Jennifer Sims-Mourtada and Ebrahim Delpassand
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1528;
Izabela Tworowska
1Chemistry, RadioMedix Inc., Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Sims-Mourtada
1Chemistry, RadioMedix Inc., Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ebrahim Delpassand
1Chemistry, RadioMedix Inc., Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1528

Objectives To synthesize novel 1,2,3-triazole-linked radiolabeled agents by click chemistry

Methods Chelating agents, DO2A- and DO3A-based, were functionalized using excess of alkyne halides (3-bromo-1-propyne or 4-bromo-1-butyne) in the presence of base and were purified by either crystallization or silica gel chromatography. These novel chelating agents were used in copper-catalyzed click reactions with azide-functionalized carbohydrates (acetyl-O-protected beta-D-glucopyranosyl 1’-azide and 2’-azide) in tBuOH/H2O. Final products of click reactions were purified by silica gel chromatography. Alkynyl-modified chelating agents and their carbohydrate click products were labeled with 68GaCl3 in 0.5M NH4OAc at 650C for 15 min. Their radiochemical purity and yield (RCY%) were assessed by iTLC and radio-HPLC. Cellular uptake studies of click-compounds were performed in A549 lung adenocarcinoma cell line in the presence or absence of glucose.

Results Alkynyl-modified chelating agents were obtained with a total yield of 45-67%. Their structures were confirmed by ESI analysis and 1D 1H NMR spectroscopy. The radiochemical yield of 68Ga-labeled alkynyl-tracers reached more than 98% as assessed by iTLC. Carbohydrate-click-conjugates were obtained with final yield of 34-51%. Their labeling with 68GaCl3 proceeded with RCY >97%. In vitro studies revealed 10-times higher uptake of the 68Ga-labeled carbohydrate-click conjugates in A549 cancer cells compared to 68Ga-DOTA. The results of stability tests of alkynyl-modified chelating agents and their carbohydrate-click-conjugates will be discussed.

Conclusions Novel alkynyl-containing chelating agents were synthesized by modification of two class of tetraaza-macrocyclic compounds, DO2A and DO3A-based. These new attractive tracers allow for selective attachment of azide-modified tumor targeting ligands. Purification of their conjugates is facilitated by introduction of 1,2,3-triazole ring in the “click reaction.” The results of our cellular uptake studies suggest that 68Ga-labeled carbohydrate-click-conjugates are transported through glucose transporters

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Application of click chemistry in the synthesis of 68Ga-labeled agents
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Application of click chemistry in the synthesis of 68Ga-labeled agents
Izabela Tworowska, Jennifer Sims-Mourtada, Ebrahim Delpassand
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1528;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Application of click chemistry in the synthesis of 68Ga-labeled agents
Izabela Tworowska, Jennifer Sims-Mourtada, Ebrahim Delpassand
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1528;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Technologies - Radioactive and Nonradioactive Probes: Novel Radioactive Probes

  • Streptavidin (SA)-trastuzumab (Tmab) Fab for linking biotinylated (Bi) multi-chelating site polymers (MCPs) for amplifying the delivery of 111In to HER2-positive breast cancer cells
  • Tumor localization and mouse-derived dosimetry projection for Ga-68-NODAGA-RGD PET
  • Microfluidic production of 18F-labeled TSPO ligands
Show more Molecular Targeting Technologies - Radioactive and Nonradioactive Probes: Novel Radioactive Probes

Novel Radioactive Probes Posters

  • Streptavidin (SA)-trastuzumab (Tmab) Fab for linking biotinylated (Bi) multi-chelating site polymers (MCPs) for amplifying the delivery of 111In to HER2-positive breast cancer cells
  • Tumor localization and mouse-derived dosimetry projection for Ga-68-NODAGA-RGD PET
  • Microfluidic production of 18F-labeled TSPO ligands
Show more Novel Radioactive Probes Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire